These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5371208)

  • 1. [Nephropathy due to gold therapy, clinical and electron microscopic studies].
    Brass H; Lapp H
    Arch Klin Med; 1969; 216(5):371-83. PubMed ID: 5371208
    [No Abstract]   [Full Text] [Related]  

  • 2. Gold nephropathy in rheumatoid arthritis and in juvenile chronic arthritis.
    Rovenská E; Kapeller K; Rossmann P
    Czech Med; 1979; 2(3):125-33. PubMed ID: 535499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal biopsy appearances in rheumatoid disease.
    Sellars L; Siamopoulos K; Wilkinson R; Leohapand T; Morley AR
    Clin Nephrol; 1983 Sep; 20(3):114-20. PubMed ID: 6627762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nephropathy prototype of membranous glomerulonephritis.
    Tönroth T; Skrifvars B
    Am J Pathol; 1974 Jun; 75(3):573-90. PubMed ID: 4600774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphology and pathogenesis of glomerular renal lesions in gold nephropathy].
    Waldmann G; Henzgen S
    Zentralbl Allg Pathol; 1983; 128(1-2):41-52. PubMed ID: 6415954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphological pictures of renal biopsy specimens in glomerulopathies related to rheumatoid arthritis (RA)].
    Danilewicz M; Wagrowska-Danilewicz M
    Przegl Lek; 1994; 51(1):5-8. PubMed ID: 8208996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracapillary proliferative glomerulonephritis and pulmonary purpura in a patient with rheumatoid arthritis treated with gold salts].
    Bontempini L; Colombari R; Lupo A; Malena M; Doglioni C; Ghimenton C
    Pathologica; 1986; 78(1057):647-55. PubMed ID: 3114704
    [No Abstract]   [Full Text] [Related]  

  • 9. Gold nephropathy.
    Tubbs RR; Valenzuela R; McCormack LJ; Pohl MA
    N Engl J Med; 1977 Jun; 296(24):1413-4. PubMed ID: 859552
    [No Abstract]   [Full Text] [Related]  

  • 10. Gold-associated nephropathy.
    Francis KL; Jenis EH; Jensen GE; Calcagno PL
    Arch Pathol Lab Med; 1984 Mar; 108(3):234-8. PubMed ID: 6365028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotic syndrome due to gold salts (apropos of 4 cases)].
    Renier JC; Boasson M; Bernat M; Fressinaud P
    Sem Hop; 1973 Mar; 49(12):881-9. PubMed ID: 4352984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long term treatment of chronic glomerulonephritis, clinical course and results of renal biopsies].
    Brass H; Lapp H; Heintz R
    Arch Klin Med; 1969; 216(4):303-23. PubMed ID: 4983036
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis.
    Nakano M; Ueno M; Nishi S; Shimada H; Hasegawa H; Watanabe T; Kuroda T; Sato T; Maruyama Y; Arakawa M
    Clin Nephrol; 1998 Sep; 50(3):154-60. PubMed ID: 9776418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental glomerulonephritis in rats.
    Fennell RH; Pardo VM
    Lab Invest; 1967 Nov; 17(5):481-8. PubMed ID: 6078245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Membranous nephropathy in rheumatoid arthritis probably unrelated to gold therapy].
    Nagai Y; Hayashi I; Hirata K; Ger YC; Tsujimoto S; Kawamura S
    Nihon Jinzo Gakkai Shi; 1986 Jan; 28(1):79-85. PubMed ID: 3712850
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal tubular dysfunction as a complication of gold therapy in patients with rheumatoid arthritis.
    Iesato K; Mori Y; Ueda S; Wakashin Y; Wakashin M; Matsui N; Inoue S; Okuda K
    Clin Nephrol; 1982 Jan; 17(1):46-52. PubMed ID: 7035044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combined immunosuppressive-cytostatic treatment on antibody-dependent cellular cytotoxicity of patients with chronic glomerulonephritis.
    Láng I; Fekete B; Kenéz B; Nagy ZK; Gergely P
    Acta Med Acad Sci Hung; 1977; 34(4):247-50. PubMed ID: 618056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythematodes provocation by gold therapy in primary chronic polyarthritis].
    Goerz G
    Dtsch Med Wochenschr; 1969 Oct; 94(40):2040-5. PubMed ID: 5356330
    [No Abstract]   [Full Text] [Related]  

  • 19. Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
    Taniguchi Y; Yorioka N; Kumagai J; Ito T; Yamakido M; Taguchi T
    Clin Nephrol; 1999 Oct; 52(4):253-5. PubMed ID: 10543328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological and clinical features of diabetic nephropathy].
    Raszeja-Wanic B
    Przegl Lek; 1973; 30(5):466-7. PubMed ID: 4579249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.